Ozempic face
“Ozempic face” is the popular term for the hollowed, aged facial appearance some people develop during rapid weight loss: sunken cheeks and temples, looser skin, more visible folds. The phrase was coined by a New York dermatologist in 2022 and stuck because it’s vivid — but it’s also misleading in two ways.
It’s weight loss, not the drug
There is no semaglutide-specific effect on facial tissue. Losing a lot of weight quickly reduces the facial fat that gives cheeks their fullness — the same look follows bariatric surgery or any major weight loss. The face simply has nowhere to hide fat loss, and skin that was stretched doesn’t always fully retract, especially with age.
It’s also not universal
How visible it gets depends on how much weight is lost and how fast, plus age, genetics, sun history, and where your body preferentially stores and releases fat. Plenty of people lose significant weight with modest facial change.
What people do about it
- Slow the rate: a gentler loss curve gives skin more time to adapt — one of several reasons prescribers don’t race titration.
- Protein and strength training: can’t target the face, but preserve overall tissue quality during loss (see lean mass loss).
- Dermatology options: fillers and skin treatments exist for people who want them; that’s a cosmetic-medicine conversation.
Mostly, the term is worth knowing so a scary-sounding phrase doesn’t read as a hidden drug danger. It’s the oldest trade-off in weight loss with a new name.